{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:32:54Z","timestamp":1771489974653,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00266-024-04608-8","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:10:18Z","timestamp":1735848618000},"page":"4087-4095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Efficacy of Heparin and Nitroglycerin in Managing Vascular Embolism Complications from Polycaprolactone (PCL) Fillers: A Clinical Study"],"prefix":"10.1007","volume":"49","author":[{"given":"Aawrish","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunli","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-2415","authenticated-orcid":false,"given":"Haiyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"4","key":"4608_CR1","doi-asserted-by":"publisher","first-page":"E3578","DOI":"10.1097\/GOX.0000000000003578","volume":"9","author":"DJ McKeown","year":"2021","unstructured":"McKeown DJ (2021) Impact of minimally invasive aesthetic procedures on the psychological and social dimensions of health. Plast Reconstr Surg Glob Open 9(4):E3578. https:\/\/doi.org\/10.1097\/GOX.0000000000003578","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"4608_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/CCID.S229054","volume":"13","author":"MO Christen","year":"2020","unstructured":"Christen MO, Vercesi F (2020) Polycaprolactone: How a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Invest Dermatol 13:31\u201348. https:\/\/doi.org\/10.2147\/CCID.S229054","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"2","key":"4608_CR3","doi-asserted-by":"publisher","first-page":"14770","DOI":"10.1111\/dth.14770","volume":"34","author":"JY Hong","year":"2021","unstructured":"Hong JY, Kim JH, Kwon TR, Hong JK, Li K, Kim BJ (2021) In vivo evaluation of novel particle-free polycaprolactone fillers for safety, degradation, and neocollagenesis in a rat model. Dermatol Ther 34(2):14770. https:\/\/doi.org\/10.1111\/dth.14770","journal-title":"Dermatol Ther"},{"issue":"12","key":"4608_CR4","doi-asserted-by":"publisher","first-page":"NP484","DOI":"10.1093\/asj\/sjz050","volume":"39","author":"JS Kim","year":"2019","unstructured":"Kim JS (2019) Changes in dermal thickness in biopsy study of histologic findings after a single injection of polycaprolactone-based filler into the dermis. Aesthet Surg J 39(12):NP484\u2013NP494. https:\/\/doi.org\/10.1093\/asj\/sjz050","journal-title":"Aesthet Surg J"},{"key":"4608_CR5","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.2147\/ccid.s385202","volume":"15","author":"M Angelo-Khattar","year":"2022","unstructured":"Angelo-Khattar M (2022) Objective assessment of the long-term volumizing action of a polycaprolactone-based filler. Clin Cosmet Investig Dermatol 15:2895\u20132901. https:\/\/doi.org\/10.2147\/ccid.s385202","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"4608_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/asj\/sjab425","volume":"42","author":"C Zheng","year":"2022","unstructured":"Zheng C, Fu Q, Zhou GW et al (2022) Efficacy of percutaneous intraarterial facial\/supratrochlear arterial hyaluronidase injection for treatment of vascular embolism resulting from hyaluronic acid filler cosmetic injection. Aesthet Surg J 42(6):649\u2013655. https:\/\/doi.org\/10.1093\/asj\/sjab425","journal-title":"Aesthet Surg J"},{"issue":"8","key":"4608_CR7","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/jocd.13518","volume":"19","author":"SL Lin","year":"2020","unstructured":"Lin SL, Christen MO (2020) Polycaprolactone-based dermal filler complications: a retrospective study of 1111 treatments. J Cosmet Dermatol 19(8):1907\u20131914. https:\/\/doi.org\/10.1111\/jocd.13518","journal-title":"J Cosmet Dermatol"},{"issue":"SUPPL. 2","key":"4608_CR8","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1524-4725.2009.01346.x","volume":"35","author":"AP Sclafani","year":"2009","unstructured":"Sclafani AP, Fagien S (2009) Treatment of injectable soft tissue filler complications. Dermatol Surg 35(SUPPL. 2):1672\u20131680. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01346.x","journal-title":"Dermatol Surg"},{"issue":"3","key":"4608_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1473-2165.2011.00562.x","volume":"10","author":"R Kassir","year":"2011","unstructured":"Kassir R, Kolluru A, Kassir M (2011) Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature. J Cosmet Dermatol 10(3):224\u2013231. https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00562.x","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"4608_CR10","doi-asserted-by":"publisher","first-page":"e2173","DOI":"10.1097\/GOX.0000000000002173","volume":"7","author":"V Chatrath","year":"2019","unstructured":"Chatrath V, Banerjee PS, Goodman GJ, Rahman E (2019) Soft tissue filler-associated blindness: a systematic review of case reports and case series. Plast Reconstr Surg Glob Open 7(4):e2173. https:\/\/doi.org\/10.1097\/GOX.0000000000002173","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"4608_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-024-03969-4","author":"A Khan","year":"2024","unstructured":"Khan A, Gong L, Wang Y et al (2024) Combination administration of heparin and nitroglycerin for the treatment of polycaprolactone-induced intravascular embolism: a preclinical investigation. Aesthet Plast Surg. https:\/\/doi.org\/10.1007\/s00266-024-03969-4","journal-title":"Aesthet Plast Surg"},{"key":"4608_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-642-23056-1_3","volume":"207","author":"E Gray","year":"2012","unstructured":"Gray E, Hogwood J, Mulloy B (2012) The anticoagulant and antithrombotic mechanisms of heparin. Handb Exp Pharmacol 207:43\u201361. https:\/\/doi.org\/10.1007\/978-3-642-23056-1_3","journal-title":"Handb Exp Pharmacol"},{"issue":"20","key":"4608_CR13","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.3390\/molecules27206968","volume":"27","author":"L Zang","year":"2022","unstructured":"Zang L, Zhu H, Wang K, Liu Y, Yu F, Zhao W (2022) Not just anticoagulation\u2014new and old applications of heparin. Molecules 27(20):6968. https:\/\/doi.org\/10.3390\/molecules27206968","journal-title":"Molecules"},{"issue":"12","key":"4608_CR14","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/jth.13555","volume":"14","author":"HC Hemker","year":"2016","unstructured":"Hemker HC (2016) A century of heparin: past, present and future. J Thromb Haemost 14(12):2329\u20132338. https:\/\/doi.org\/10.1111\/jth.13555","journal-title":"J Thromb Haemost"},{"issue":"19","key":"4608_CR15","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.jacc.2017.09.1064","volume":"70","author":"S Divakaran","year":"2017","unstructured":"Divakaran S, Loscalzo J (2017) The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. J Am Coll Cardiol 70(19):2393\u20132410. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1064","journal-title":"J Am Coll Cardiol"},{"key":"4608_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000100067.62876.50","author":"AL Kleschyov","year":"2003","unstructured":"Kleschyov AL, Oelze M, Daiber A, Huang Y, Mollnau H, Schulz E, M\u00fcnzel T (2003) Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res. https:\/\/doi.org\/10.1161\/01.res.0000100067.62876.50","journal-title":"Circ Res"},{"issue":"2","key":"4608_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/bcp.13804","volume":"85","author":"K Zhou","year":"2019","unstructured":"Zhou K, Parker JD (2019) The role of vascular endothelium in nitroglycerin-mediated vasodilation. Br J Clin Pharmacol 85(2):377\u2013384. https:\/\/doi.org\/10.1111\/bcp.13804","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"4608_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ph9030038","volume":"9","author":"EI Oduah","year":"2016","unstructured":"Oduah EI, Linhardt RJ, Sharfstein ST (2016) Heparin: past, present, and future. Pharmaceuticals 9(3):38. https:\/\/doi.org\/10.3390\/ph9030038","journal-title":"Pharmaceuticals"},{"issue":"6","key":"4608_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0002-9343(01)00687-8","volume":"110","author":"C Kearon","year":"2001","unstructured":"Kearon C, Gent M (2001) Heparin therapy for deep vein thrombosis: from hospital to home. Am J Med 110(6):501\u2013502. https:\/\/doi.org\/10.1016\/s0002-9343(01)00687-8","journal-title":"Am J Med"},{"issue":"24","key":"4608_CR20","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1161\/01.cir.103.24.2994","volume":"103","author":"Y Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V, American Heart Association (2001) Guide to anticoagulant therapy: heparin : a statement for healthcare professionals from the American Heart Association.\u00a0Circulation 103(24):2994\u20133018. https:\/\/doi.org\/10.1161\/01.cir.103.24.2994","journal-title":"Circulation"},{"issue":"2","key":"4608_CR21","doi-asserted-by":"publisher","first-page":"e5343","DOI":"10.1002\/ccr3.5343","volume":"10","author":"Y Kalantari","year":"2022","unstructured":"Kalantari Y, Sadeghzadeh-Bazargan A, Aryanian Z, Hatami P, Goodarzi A (2022) First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid polycaprolactone dermal filler following COVID-19 vaccination: a case report and a review of the literature. Clin Case Rep 10(2):e5343. https:\/\/doi.org\/10.1002\/ccr3.5343","journal-title":"Clin Case Rep"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-04608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-024-04608-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-04608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:41:06Z","timestamp":1754484066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-024-04608-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":21,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4608"],"URL":"https:\/\/doi.org\/10.1007\/s00266-024-04608-8","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Complete\u00a0written informed consent\u00a0was obtained from the patient for the publication of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}